The management of Stevens-Johnson syndrome and toxic epidermal necrolysis begins with a high clinical suspicion during the initial prodromal phase.

This stage often presents with malaise and fever, quickly followed by the development of painful erythematous macules that may progress to confluent sheets of denuded skin. The most critical intervention in this early window is the identification and immediate cessation of the causative agent. Clinical data confirms that the earlier a culprit drug is withdrawn, the better the overall prognosis for the patient.

Clinicians often employ specialized algorithms to determine which medication is most likely responsible for the reaction. These tools assess the timing between drug initiation and the onset of symptoms, the drug’s typical half-life, and known associations between certain drug classes and these severe cutaneous reactions. High-risk medications often include specific antiepileptics, certain antibiotics like sulfonamides, and particular anti-inflammatory agents. Once a medication is suspected, it must be halted immediately, and the patient should be transitioned to a high-level care environment such as an intensive care unit or a specialized burn center. This immediate action is the foundation of all subsequent treatment, as continued exposure to the trigger can exacerbate the immune-mediated destruction of keratinocytes.